Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
EU court signals tough stance on ‘pay-for-delay’ pharma deals
Europe
Advocate general recommends upholding €60.48 million fine against Teva and Cephalon for anti-competitive modafinil settlement.   27 March 2025
Panitch Schwarze hires experienced ex-USPTO examiner
Careers
Combining USPTO work with a background in molecular biology, immunology, and plant biochemistry, the new counsel brings patent practitioner and examiner skills to the firm.   27 March 2025
Fed Circ affirms generic’s litigation costs of $12m are tax-deductible
Americas
Court of Appeals rules defence costs in Hatch-Waxman cases are deductible as ordinary business expenses | US IRS stands to pay tax rebate to generics manufacturer.   25 March 2025
Americas
Danish biotech prepares defence against allegations of trade secret misappropriation | AbbVie claims two former employees helped ProfoundBio use confidential tech to improve its cancer treatment pipeline ahead of Genmab acquisition.   25 March 2025
Europe
Supplementary Protection Certificate rules interpreted in different ways have left the EU’s generic and biosimilar industries hungry for clarity, explains Jiri Slavik of Adalvo.   25 March 2025
Europe
New hope for 10x’ preliminary injunction after EPO Opposition Division ruling | Patent at issue concerns single-cell spatial molecular imaging products.   20 March 2025
Americas
Trio files multiple patent infringement lawsuits to protect blockbuster prostate cancer drug | Latest suits target Hetero and Aizant, following similar actions against Apotex, BDR Pharmaceuticals, and CIPLA.   20 March 2025
Americas
Companies are transforming IP from a defensive tool into a revenue-generating powerhouse. Marisa Woutersen at the WIPR Summit 2025 hears trends in licensing, platform-based monetisation, and litigation funding.   18 March 2025
Americas
Complaint centres on AI-powered tools for cancer diagnostics | Tempus says its rival has a history of deliberately copying competitors’ technologies.   18 March 2025
Americas
As IP professionals wait for agency cutbacks to be felt down the chain, the advice is to stay informed, manage budgets wisely, and use a mix of protections to weather any disruption, finds Marisa Woutersen.   13 March 2025